We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+13.81%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$5.32B
AUM Growth
+$342M
Cap. Flow
-$210M
Cap. Flow %
-3.94%
Top 10 Hldgs %
44.57%
Holding
573
New
225
Increased
108
Reduced
68
Closed
168

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$96.5M
2
GFL icon
GFL Environmental
GFL
+$92.9M
3
QDEL icon
QuidelOrtho
QDEL
+$79.1M
4
ALAB icon
Astera Labs
ALAB
+$73.9M
5
NTRA icon
Natera
NTRA
+$60.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.34%
2 Technology 17.7%
3 Healthcare 16.82%
4 Financials 10.98%
5 Real Estate 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAS icon
201
Cintas
CTAS
$81.6B
$538K 0.01%
+3,132
New +$482K
KEX icon
202
Kirby Corp
KEX
$7.39B
$535K 0.01%
+5,610
New +$473K
RACE icon
203
Ferrari
RACE
$76.7B
$533K 0.01%
1,223
+125
+11% +$48.4K
FIVN icon
204
FIVE9
FIVN
$2.45B
$533K 0.01%
+8,582
New +$596K
LPX icon
205
Louisiana-Pacific
LPX
$5.12B
$530K 0.01%
+6,311
New +$454K
MATX icon
206
Matsons
MATX
$6.66B
$524K 0.01%
4,659
+2,740
+143% +$309K
CHH icon
207
Choice Hotels
CHH
$4.93B
$520K 0.01%
+4,118
New +$492K
HAE icon
208
Haemonetics
HAE
$4.95B
$518K 0.01%
+6,074
New +$477K
LZB icon
209
La-Z-Boy
LZB
$1.35B
$515K 0.01%
13,693
-6,363
-32% -$232K
OKTA icon
210
Okta
OKTA
$23.5B
$513K 0.01%
+4,907
New +$453K
EQIX icon
211
Equinix
EQIX
$105B
$513K 0.01%
+621
New +$522K
TKO icon
212
TKO Group
TKO
$14.1B
$508K 0.01%
+5,882
New +$490K
ANSS
213
DELISTED
Ansys
ANSS
$507K 0.01%
+1,460
New +$494K
ENOV icon
214
Enovis
ENOV
$1.5B
$505K 0.01%
+8,092
New +$484K
TENB icon
215
Tenable Holdings
TENB
$3.79B
$505K 0.01%
+10,222
New +$485K
AX icon
216
Axos Financial
AX
$5.48B
$505K 0.01%
+9,345
New +$492K
AMP icon
217
Ameriprise Financial
AMP
$49.1B
$504K 0.01%
1,150
+443
+63% +$177K
JAZZ icon
218
Jazz Pharmaceuticals
JAZZ
$16.5B
$504K 0.01%
+4,187
New +$513K
DHT icon
219
DHT Holdings
DHT
$3.2B
$502K 0.01%
+43,650
New +$479K
HBM icon
220
Hudbay
HBM
$13.4B
$501K 0.01%
71,537
+26,760
+60% +$156K
PRM icon
221
Perimeter Solutions
PRM
$5.15B
$497K 0.01%
67,045
+19,110
+40% +$103K
GPK icon
222
Graphic Packaging
GPK
$3.54B
$495K 0.01%
+16,955
New +$443K
MDLZ icon
223
Mondelez International
MDLZ
$82.3B
$494K 0.01%
7,058
-4,783
-40% -$349K
MOG.A icon
224
Moog Inc Class A
MOG.A
$12.3B
$491K 0.01%
+3,073
New +$452K
GMS
225
DELISTED
GMS Inc
GMS
$490K 0.01%
+5,034
New +$440K

Similar funds

Lee Ainslie's Q1 2024 Portfolio in Review

As of Q1 2024, Lee Ainslie held 573 positions worth $5.32B, up 6.9% from $4.98B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Lee Ainslie withdrew a net $210M in Q1 2024, closing 168 positions and reducing 68 holdings. Its most notable exit was Immunogen Inc, an estimated $73.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lee Ainslie opened a new position in Electronic Arts worth $93.2M.

  • Lee Ainslie's largest Q1 2024 buy was Electronic Arts: 702,830 shares worth $93.2M.
  • Lee Ainslie added most to Starbucks in Q1 2024, an estimated $51.2M increase.
  • Lee Ainslie's biggest Q1 2024 reduction was Coupang, cutting an estimated $307M.
  • Lee Ainslie fully exited Immunogen Inc in Q1 2024, selling an estimated $73.9M.
  • Lee Ainslie's ten largest holdings make up 45% of its $5.32B portfolio in Q1 2024.
  • Lee Ainslie opened 225 new positions and closed 168 in Q1 2024.
  • Lee Ainslie's portfolio value rose 6.9% quarter-over-quarter to $5.32B.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.